Drug intelligence / Profile preview

Celergen

Development stage
Preclinical
Lead developer
Celergén
Modality
Recombinant Proteins and Enzymes, Peptides, Small Molecules
Administration
Oral
01

Overview

Celergen is an **oral dietary supplement** described as the "first cell therapy supplement" formulated in Switzerland for anti-aging and regenerative health benefits. The main active ingredient is a patented **BioDNA Cellular Marine Complex**, derived from **marine (deep-sea salmon and herring) DNA and peptides**, and formulated with additional ingredients including **hydrolyzed collagen peptides (Peptide E Collagen), marine peptides, natural lutein, coenzyme Q10, and selenium**. Celergen claims mechanisms including antioxidative, anti-inflammatory, and immune-modulatory effects, supporting cell repair, rejuvenation, and protection against oxidative stress. It is not a pharmaceutical but is rather classified as a high-risk food supplement with no approved therapeutic claims. It is primarily indicated as an anti-aging formula, with studies reporting benefits in joint pain, asthenia (fatigue), fibromyalgia, skin aging, bone health, and general well-being, but it is not approved for any disease treatment or prevention and lacks established pharmacological targets[1][2][3][4][5][7][8][9][10].

Brand names
CelergenCelergen Switzerland
Other names
CelergenCelergen cell therapyCelergen BioDNA Cellular Marine Complex

Beyond the preview

Go deeper on Celergen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Celergen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call